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Introduction
Genetic disorders of skeletal development are a large, extremely heterogeneous group of conditions that may present anytime from the prenatal period to adulthood. The estimated incidence of disorders of skeletal development manifesting in the neonatal period is 15.7 per 100,000 births. Long-term prognosis ranges from inevitable death shortly after birth to survival into adulthood with normal intellectual development. In the neonatal period, respiratory compromise is the leading cause of morbidity and mortality. Skeletal dysplasias are developmental disorders of chondro-osseous tissues or an "abnormal organization of cells into tissue and its morphologic result." (1) These disorders are the result of an insult that occurs after organogenesis but persists throughout later stages of development into postnatal life. Dysplasias are referred to as primary if they result from mutations in genes expressed in chondro-osseous tissues and secondary if they result from extraosseous factors that affect development of bone. Dysplasias continue to affect the skeleton through late pre-and postnatal life, lead-ing to short stature, differing clinical characteristics with age, and in some cases, an increased risk of primary malignancies of chondro-osseous tissues. In contrast, dysostoses are "malformations of single bones, alone or in combination." (1) They are typically the result of a discrete insult during organogenesis. As such, they are static lesions without risk of progression or malignant degeneration and usually are not associated with short stature. Key definitions important in the diagnosis of these disorders are summarized in Table 1 .
To date, 372 disorders have been described and classified into 37 groups. (2) As the number of disorders of skeletal development has increased and understanding of their molecular causes has grown, this classification system has evolved into a complex amalgam of clinical, radiographic, biochemical, and molecular features. Some classification groups are based purely on molecular cause (eg, FGFR3 group, type II collagen group), others are based on radiologic findings (eg, metaphyseal dysplasias group, increased bone density group), and yet others are based on a combination of clinical and radiographic features (eg, mesomelic and rhizomesomelic dysplasias, bent bone dysplasias group).
This bewildering array of disorders and terminology can make the approach to a newborn who has a suspected disorder of skeletal development overwhelming for even the most experienced clinician. In this article, we review basic aspects of skeletal development, discuss how to approach an infant who has a suspected skeletal dysplasia or dysostosis, summarize common and important disorders of skeletal development presenting in the neonatal period, and present advances in treatment. 
Case Presentation

Overview of Skeletal Development
Development of the skeleton begins very early in embryonic life, starting with patterning of the somites during the end of the third week and formation of the limb buds during the fourth week of embryogenesis. Complex molecular pathways mold the somites into the developing axial skeleton, which ultimately consists of the vertebral column, scapula, ribs, and pelvis. Distinct, yet equally sophisticated developmental signals direct the primordial limb buds to form the mature appendicular skeleton. Disruptions in these early patterning events classically result in dysostoses ( Table 2) .
Patterning of the skeleton is followed during the fifth week of development with the formation of cartilage from mesenchyme or embryonic connective tissue. The skeleton subsequently develops through two primary mechanisms: intramembranous ossification and endochondral ossification. In intramembranous ossification, neural crest-derived mesenchymal stem cells condense and differentiate directly into bone. This process is involved primarily in the formation of the flat bones of the skull and proximal portions of the clavicles. The remain- der of the skeleton is formed through endochondral ossification, whereby mesenchymal stem cells initially create a well-organized cartilage structure that subsequently is converted to bone. A number of disorders result from disruption of this normal differentiation process, leading to a phenotype of abnormal skeletal patterning as well as a defect in skeletal growth. Because these disorders combine features of dysotosis and dysplasia, they sometimes are referred to as dysostoplasias. Prototypic examples include campomelic dysplasia and cleidocranial dysplasia (Table 2) . Newly formed chondrocytes within the immature skeletal architecture subsequently undergo an elaborate process involving proliferation, differentiation, and growth. Throughout these changes, the chondrocytes are supported by a complex array of organic molecules, referred to as the extracellular matrix. This matrix, which includes collagen, proteoglycans, and glycoproteins, not only provides critical structural support but also interacts directly with the signaling pathways modulating chondrocyte development. A disruption of either this complex structural matrix or the intricate molecular signaling pathways regulating chondrocyte growth and development leads to many of the known skeletal dysplasias.
The final step in the formation of bone is mineralization. Osteoblasts deposit an osteoid matrix, which becomes impregnated with hydroxyapatite crystals. This calcified material provides bone with its characteristic 
Initial Diagnostic Approach
The evaluation and initial treatment of the neonate who has a suspected disorder of skeletal development is a multidisciplinary endeavor, requiring, at minimum, the expertise of neonatologists, medical geneticists, and radiologists. After addressing any respiratory compromise and clinically stabilizing the infant, initial evaluation should begin with a detailed history and physical examination. A comprehensive prenatal history should be elicited, looking for potential infectious, environmental, or teratogenic disruptions of skeletal development. A family history also may be informative because many of the disorders of skeletal development are transmitted in an autosomal dominant pattern. Theoretically, affected individuals transmit the trait to 50% of their offspring with this mode of inheritance. In actuality, the numbers are lower due to germline mosaicism and incomplete penetrance. More often, there is no family history of the disorder due to de novo mutations. More than 80% of cases of achondroplasia, for example, are due to de novo mutations in FGFR3, and there is a well-described association between these new mutations and advanced paternal age.
A head-to-toe physical examination should be performed, focusing on physical features and other birth defects that may aid in determining a specific diagnosis ( Table 3 ). The head shape, fontanelles, and suture width are examined, looking for the presence of a craniosynostosis. In addition, any dysmorphic facial features should be noted. The oral cavity is examined for cleft palate, gingival frenulae, and abnormal dentition. Consultation with an ophthalmologist may be indicated to examine for retinitis pigmentosa, cataracts, colobomas, or myopia. Abnormalities of the skin, hair, and nails should be noted and the joints examined carefully for any abnormalities, such as hyperlaxity or contractures. In noting any asymmetry or deformity of the extremities, it is important to look specifically for syndactyly or an abnormal number of digits. Careful cardiac and neurologic examinations should be completed to look for evidence of congenital heart disease or central nervous system (CNS) dysfunction, respectively. Finally, a complete skeletal survey should be performed and consultation with a medical geneticist and pediatric radiologist obtained.
Radiology
A skeletal survey performed for the assessment of a potential abnormality of skeletal development should include the following views: anteroposterior (AP) and lateral skull; AP and lateral thoracolumbar spine; and AP images of chest, pelvis, upper and lower limbs, and hands/feet. Additional films may be obtained to assess specific abnormalities or if asymmetry exists.
A brief review of all of the radiographs can identify the portion(s) of the skeleton that appear to be affected most severely. Common terms used to refer to regions of the axial skeleton appear in Table 4 . Abnormalities of the appendicular skeleton are referred to by the region most affected within individual long bones (epiphyseal, metaphyseal, diaphyseal) as well as along the proximo-distal axis. Shortening that predominantly involves the proximal, middle, or distal region is referred to as rhizomelic, mesomelic, or acromelic, respectively.
In the neonate, epiphyseal dysplasias typically manifest as delayed epiphyseal ossification. The following ossification centers are expected to be seen radiographically in a term or near-term neonate: humeral head, distal femoral, proximal tibial, calcaneus, and talus. Radiographic findings of metaphyseal dysplasias include irregular, broad, and cupped (or lucent) metaphyses. The term "overtubulated" (metaphyseal flaring resulting in a sharp transition between the metaphysis and diaphysis) is used occasionally to describe the radiographic findings of metaphyseal dysplasias. Diaphyseal dysplasias present as relatively wide diaphyses with narrow metaphyses and often are referred to as "undertubulated" bones. Involvement of the spine (most often platyspondyly in the neonate) frequently is seen in conjunction with abnormalities of the long bones. In such cases, the categorization is spondyloepiphyseal, spondylometaphyseal, or spondyloepimetaphyseal dysplasia. This basic information of radiographic and clinical categorization provides the starting point for a query of major reference books and electronic databases.
For examination of individual bones, Offiah and Hall (4) have proposed a helpful mnemonic of "the five S's": Structure, Shape, Size, Sum, and Soft tissues. Peculiar or unusual features of individual bones may provide helpful diagnostic clues. It is important to look for increased or decreased bone density, abnormal bony growths, and any bones that appear to be of an unusual shape. The size of individual bones, particularly with respect to the remainder of the skeleton, should be considered. Finally, it is important to note whether there is an abnormal number or fusion of any bones and whether there appears to be any soft-tissue involvement.
Additional Diagnostic Testing
Depending on the specific disorder of skeletal development, it may be possible to establish a diagnosis with a clinical history, physical examination, and skeletal survey alone. In other cases, additional evaluation may be required. Histologic examination of bone and cartilage may be very informative, although it can be obtained only through bone biopsy. Therefore, it often is reserved for autopsy cases or for infants and children undergoing a surgical procedure for another indication. Biochemical analysis may be helpful in specific cases, such as examination of type I collagen in osteogenesis imperfecta. Finally, DNA testing now is available for many disorders of skeletal development and generally is preferred because it is less invasive and can provide a definitive diagnosis. The utility of these tests varies greatly between disorders, and interpretation of results can be difficult, so consultation with a medical geneticist is advised.
Prenatal Diagnosis of Fetal Skeletal Dysplasias
Due to improvements in fetal imaging technology, it now is possible to recognize disorders of skeletal development in the prenatal period. Suspicion for a fetal skeletal dysplasia should be raised when routine ultrasonographic measurements of femora or humeri fall below the 5th percentile or other skeletal abnormalities are apparent. Any fetus meeting these criteria should be referred to a high-risk perinatal center that has expertise in fetal skeletal dysplasias for complete ultrasonographic evaluation. Additional imaging studies may include three-dimensional ultrasonography for better definition of craniofacial abnormalities and fetal magnetic resonance imaging if there is a concern for spinal defects. Despite these sophisticated imaging modalities, establishing a definitive diagnosis in the prenatal period remains very difficult. This dilemma presents a major challenge for both obstetricians and neonatologists in In some cases, prenatal DNA testing may be employed to help establish a definitive fetal diagnosis. For families that have a history of a specific disorder of skeletal development that has been confirmed with molecular methods, mutation analysis may be performed on DNA obtained by chorionic villus sampling or amniocentesis. In the absence of a family history, large gene sizes, "private" mutations, and disorders of unknown cause may hinder timely molecular diagnosis. In many cases, however, it still may be possible to perform successful mutation analysis when a known, common mutation exists (as with FGFR3 mutations in thanatophoric dysplasia and achondroplasia). The interested reader is referred to Krakow and associates (5) for an excellent and more complete discussion of this topic.
Selected Disorders of Skeletal Development With Neonatal Onset
A summary of some of the more common and clinically important disorders of skeletal development presenting in the perinatal and neonatal periods appears in Table 5 .
Type II Collagenopathies
Achondrogenesis type II, hypochondrogenesis, Kniest dysplasia, spondyloepiphyseal dysplasia congenita (SEDc), and Stickler syndrome form a spectrum of disorders due to mutations in the COL2A1 gene that may present during the neonatal period. These disorders are charac- Infants who have achondrogenesis type II (LangerSaldino type) are the most severely affected and typically are stillborn or die within the first few hours of birth. The affected neonate has a hydropic appearance, with very short limbs, flat midface, micrognathia, and a protuberant abdomen. Cleft palate may be present. Radiographically, there is absent or severely delayed ossification of the vertebral bodies and sacrum, short ribs with a barrelshaped thorax, small iliac bones, and very short tubular bones with metaphyseal flaring and cupping (Fig. 1) .
Infants who have hypochondrogenesis have similar features but are less severely affected. The vertebral bodies are more completely ossified (although often still absent in the cervical region), and the tubular bones are not as short. The overall prognosis in this condition is still poor; although most neonates are born alive, many succumb to cardiorespiratory failure during the first few postnatal months.
Although Kniest dysplasia and SEDc usually are recognized at birth, affected infants and children often survive to adulthood and can lead active lives. As with the other type II collagenopathies, there is significant spinal involvement in Kniest dysplasia, with thoracic kyphoscoliosis and marked lumbar lordosis. Radiographs of the spine reveal flattened vertebral bodies (platyspondyly), with anterior wedging and coronal clefts in infancy. There is often a flat midface with depressed nasal bridge and occasionally cleft palate. The extremities are shortened, and joint mobility is decreased. Radiographically, delayed ossification of the capital femoral epiphyses is seen. Once ossified, these epiphyses are broad and flat. The epiphyses of other tubular bones also are deformed. Due to the importance of type II collagen in the structure of the eye and ear, affected children are at risk of myopia, retinal detachment, chronic otitis media, and hearing loss. Patients who have SEDc typically are more mildly affected than those who have Kniest dysplasia. Distinguishing radiologic features of SEDc include absence of vertebral coronal clefts in infancy and normal tubular bones of the hand and feet.
Stickler syndrome may present in infancy with cleft palate and Pierre-Robin sequence. Infants often have midface hypoplasia, a small and upturned nose, micrognathia, and joint hypermobility. Radiographic findings may be evident and most commonly are manifested as vertebral coronal clefts and widened epiphyses of the femora and tibiae. Sensorineural hearing loss, myopia, and later retinal detachment and cataracts may develop.
Disorders Involving Fibroblast Growth Factor-3 (FGFR3)
Mutations in the FGFR3 gene can lead to a variety of skeletal dysplasias that vary greatly in their severity. Thanatophoric dysplasia (TD) and achondroplasia both manifest in the neonatal period, although the former condition is much more severe, typically resulting in death due to respiratory failure in the first few days after birth. Infants affected by TD have very narrow thoraxes with consequent pulmonary hypoplasia, very short limbs, and relatively normal trunk lengths (Fig. 2) . There is typically a depressed nasal bridge and prominent fore- head. Craniosynostosis, with a "cloverleaf deformity," may be present. Skeletal survey reveals short ribs, small and flat vertebral bodies, short and broad pelvic bones, and short and broad tubular bones. There also may be abnormal development of the CNS, including megalencephaly, abnormal temporal lobe development, and disorders of neuronal migration. Rare surviving infants suffer from intellectual disability and seizures. TD has been divided into two subtypes. Type I is characterized by bowed, "telephone receiver" femurs; in type II TD, the femurs are straight and a cloverleaf skull deformity is seen. Each type is caused by distinct mutations in the FGFR3 gene. Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) also is due to FGFR3 gene mutations. It is very similar to type I TD but has a better prognosis.
Achondroplasia produces changes that are qualitatively similar to TD but invariably less severe. Patients regularly lead active, productive lives well into adulthood. On clinical examination, the limbs appear disproportionately short compared with the remainder of the body. The trunk length appears relatively normal, and the head appears disproportionately large. Moreover, the most proximal segments of the extremities are disproportionately short compared with their more distal counterparts (rhizomelic shortening). A "trident hand" is seen due to short, wide, and "coneshaped" phalanges. Radiographically, the vertebrae are slightly flat, the pelvis is abnormally shaped (round or slightly square appearance in the neonatal period), and the tubular bones are short and wide (Fig. 3) . In early infancy, hypotonia is present, and when combined with a small thorax, can lead to respiratory difficulties and predisposition to recurrent infections. As the affected patient ages, stenosis of the foramen magnum can lead to compression of the brainstem and spinal cord. Untreated, such compression can cause cardiorespiratory compromise and sudden cardiac death. Affected children may suffer from hearing loss, recurrent otitis media, and speech delay. Intellectual development is otherwise normal. Hypochondroplasia is another disorder of skeletal development due to mutations in FGFR3 and clinically is similar to achondroplasia. However, it is much less severe and usually is not recognized until the end of the first decade of life or later.
Osteogenesis Imperfecta
Osteogenesis imperfecta (OI) is a heterogeneous group of disorders characterized by increased bone fragility. As a group, they are the most common disorders of skeletal development that manifest in the neonatal period. OI initially was divided into four types based on clinical features and mode of inheritance. (7) As the molecular basis for OI has become better established, this classification system has grown to include nine types (Table 6 ). Type II (perinatal lethal) OI is the most severe form of the disorder, typically leading to death in the perinatal period or early infancy due to respiratory failure. There is diffuse osteoporosis, with multiple fractures and callus formation by the time of birth. The skull is poorly developed, and the ribs and long bones are short and take on a beaded or "wavy" appearance (Fig. 4) . OI types III through IX are characterized by moderate-to-severe bone fragility and often manifest in infancy. In addition to frequent pathologic fractures, common clinical features of OI include short stature, scoliosis, ligamentous laxity, hernias, easy bruising, and hearing loss. Many (but not all) types also are associated with blue sclerae and dentogenesis imperfecta (discolored translucent dentin that is weak and susceptible to excessive wear and damage). Wormian bones (small irregular bones of the skull along suture lines) (Fig. 5 ) may be seen. Complications include bowing of long bones with progressive deformity, mixed hearing loss, and spinal cord compression due to progressive kyphoscoliosis and vertebral fractures. Type I OI (nondeforming) is the mildest form of the disorder. Although it may be recognized occasionally in the perinatal or neonatal period due to femoral bowing or fractures, fractures typically do not occur until the affected child begins to walk.
In 90% of cases, OI is due to mutations in one of the two genes that encodes for type I collagen (COL1A1, COL1A2). Type I collagen, a major structural element in bones, tendons, ligaments, skin, and sclerae, is formed from three coiled polypeptides. The first step in its synthesis involves chemical modification (hydroxylation of proline and lysine residues), followed by the winding of two alpha-1 helices and one alpha-2 helix together into a single chain to produce procollagen. Both ends of the procollagen subsequently are cleaved to produce the final product, known as tropocollagen. Various insertions, deletions, and point mutations have been described in both genes. Deletions or mutations that lead to truncation of the alpha-helical polypeptide and decreased production of structurally normal collagen generally cause type I OI (the mildest type). Mutations that result in structural changes with qualitatively abnormal collagen cause types II, III, and IV OI. However, it is often difficult to distinguish between these types based on mutation analysis alone.
In 10% of cases of OI, no mutation can be identified in 
Chondrodysplasia Punctata Group
The chondrodysplasia punctata syndromes are characterized by small calcifications in cartilaginous epiphyses (punctuate epiphyses, stippled epiphyses) (Fig. 6 ) that are the result of dyssynchronous ossification. In addition to inherited osteochondrodysplasias, a wide range of other conditions, including peroxisomal disorders (Zellweger syndrome), chromosomal abnormalities (trisomy 18 and 21, Turner syndrome), single-gene disorders (Cornelia de Lange syndrome), metabolic disorders (GM-1 gangliosidosis, galactosialidosis), infections (congenital rubella), or toxic exposures (maternal diabetes, warfarin embryopathy) can lead to stippled epiphyses. The pattern and location of the stippling often help to establish a specific diagnosis, which is critical to accurate counseling and management. For example, Greenberg dysplasia almost always leads to death in utero or at birth, whereas the tibial-metacarpal type of chondrodysplasia punctata has a very good prognosis, with normal development and survival to adulthood. Interestingly, in all of these conditions, the epiphyseal stippling disappears by about 3 to 5 years of age, making subsequent diagnosis much more difficult.
Asphyxiating Thoracic Dystrophy (Jeune Syndrome)
Asphyxiating thoracic dystrophy is characterized by a very narrow and shallow thorax, which can lead to severe respiratory compromise. Patients have short extremities with metaphyseal irregularities, short hands and feet with postaxial polydactyly, and short middle and distal phalanges with cone-shaped epiphyses. Other associated medical problems include progressive renal disease, pancreatic and hepatic fibrosis, Hirschsprung disease, and hydrocephalus. Respiratory distress and recurrent respiratory infections are the greatest cause of morbidity and mortality during the neonatal period and infancy. The disorder is transmitted in an autosomal recessive pattern, and two genetic loci have been identified to date. A subset of cases are due to mutations in intraflageller transport protein (IFT80), located in 3q24-q26. Other cases have been mapped to the 15q13 region, but a causal gene has yet to be identified. It can be difficult to distinguish this disorder from Ellis-van Creveld syndrome.
Chondroectodermal Dysplasia (Ellis-van Creveld Syndrome)
Ellis-van Creveld syndrome, originally described in the Amish population, has many similarities with Jeune syndrome. Skeletal changes include narrow thorax (Fig. 7) , pre-or postaxial polydactyly, fusion of the metacarpals or phalanges (Fig. 8) , dysplasia of the pelvis, and progressive shortening of the extremities in a proximal-to-distal pattern. Multiple gingival frenulae are common. In contrast to Jeune syndrome, however, Ellis-van Creveld syndrome commonly is associated with congenital heart disease, hypoplastic nails (Fig. 8) , and dental anomalies (eg, natal teeth, partial odontia, enamel hypoplasia, dysplastic teeth). The most commonly seen cardiac lesions are atrial septal defect or single atrium.
Management
The care of children who have disorders of skeletal development presenting in the neonatal period is a complex, multidisciplinary effort best coordinated by a center with expertise in these conditions. Neonatologists play a crucial role in the stabilization and initial identification of affected infants because many have a variety of medical complications shortly after birth, including respiratory distress due to pulmonary hypoplasia and restrictive lung disease. Medical geneticists and radiologists play critical roles in establishing a definitive diagnosis, which is crucial to provide neonatologists and families with prognos-tic information to direct the overall course and intensity of care. Pediatric orthopedists, physical medicine and rehabilitation specialists, and physical and occupational therapists are needed to monitor the physical development of the children and address specific deformities. Depending on the disorder, a host of specialists may be involved in the affected child's care, including but not limited to pulmonology (eg, pulmonary hypoplasia, restrictive lung disease), cardiology, dentistry, nephrology, ophthalmology (eg, cataracts, retinal detachment, myopia), otorhinolaryngology, and neurosurgery (eg, stenosis of the foramen magnum, hydrocephalus). Equally important, psychologists, social workers, and family support groups take critical parts in the psychosocial care of patients and their families.
Few pharmacologic treatments are available for the management of disorders of skeletal development. Intravenous infusion of pamidronate (a bisphosphonate) has been reported to increased bone mineral density, decrease biochemical markers of bone reabsorption, and possibly decrease fracture risk in OI. This is presently the standard of care for types III and IV OI. Human growth hormone has been employed on an experimental basis to increase final adult height in several skeletal dysplasias, but its use remains controversial.
Case Continued: Evaluating a Suspected Skeletal Dysplasia
After transfer the NICU, the patient is stabilized with nasal continuous positive airway pressure. A skeletal survey is performed (Figs. 9 and 10 ) and a genetics consultation obtained. The most notable features on review of the skeletal 
